Leo Sher, M.D. A research paper, “Common osteoporosis drug associated with increased rates of depression and anxiety” has recently been published in Scientific Reports (1). Amongst the most common drug therapies for osteoporosis are bisphosphonates, including alendronate, zoledronate, ibandronate and risedronate. Other first-line options with a different molecular mechanism include denosumab and teriparatide. The author […]
Leo Sher, M.D. My commentary, “Smoking enhances suicide risk-a significant role in the COVID-19 pandemic?” has recently been published in the QJM: An International Journal of Medicine (1). A summary of my article is below: The COVID-19 outbreak has severely affected the whole world. Considerable evidence suggests that tobacco smoking is associated with increased severity […]
Nothing will ever be attempted if all possible objections must be first overcome. – Samuel Johnson (1709 -1784)
Leo Sher, M.D. The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health was founded in 2013. Currently, the WFSBP Task Force on Men’s Mental Health consists of scholars from many countries in different parts of the world. The updated list of the Task Force Members is below: Founding Chair: […]
Leo Sher, M.D. Our research paper, “CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence” was published 15 years ago in the January 2007 issue of European Neuropsychopharmacology (1). In this study, we investigated the relationship of cerebrospinal fluid (CSF) 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) levels […]
Aya Allam, M.D., Steven Lippmann, M.D. We know lots about the current omicron spread. So, what is going on with this new antiviral drug, branded as Paxlovid and made by Pfizer? This pharmaceutical was just approved for early-on therapeutic prescribing to patients at high risk to SARS-Cov-2 virus infection yielding a serious COVID-19 disease. It […]
Leo Sher, M.D. Our review, “Suicide prevention in the covid-19 era” was published in Preventive Medicine online ahead of print on September 16, 2021 and included in the November 2021 print issue of the Journal (1). A summary of our article is below: The COVID-19 pandemic is affecting the health of people all around the […]
Aya Allam, M.D., Steven Lippmann, M.D. Early in the pandemic, then President Trump contracted a COVID-19 illness and took some medications to counter his illness. He survived. One of the drugs he received was remdesivir, an antiviral pharmaceutical. Now, more recently approved to counter coronavirus infections; what is there to know about remdesivir? Further back, […]
Leo Sher, M.D. Our research report, “A circadian signal of change of season in individuals with seasonal affective disorder” was published in the December 2001 issue of the Archives of General Psychiatry (1). In animals, the circadian pacemaker regulates seasonal changes in behavior by transmitting a signal of day length to other sites in the […]
Leo Sher, M.D. Our research work, “Clinical features and psychiatric comorbidities of borderline personality disorder patients with versus without a history of suicide attempt” was published in the December 2016 issue of Psychiatry Research (1). In this study, we compared clinical features of borderline personality disorder (BPD) patients with or without a history of suicide […]
